PACAP is an islet neuropeptide which contributes to glucose-stimulated insulin secretion

被引:29
作者
Filipsson, K
Sundler, F
Ahrén, B
机构
[1] Dept Med, Malmo, Sweden
[2] Lund Univ, Dept Physiol & Neurosci, Lund, Sweden
关键词
PACAP; insulin secretion; rat islets;
D O I
10.1006/bbrc.1999.0395
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pituitary adenylate cyclase activating peptide (PACAP) is a;ubiquitously distributed neuropeptide which also is localized to pancreatic islets and stimulates insulin secretion. We examined whether endogenous PACAP within,the islets might contribute to glucose-stimulated insulin secretion by immunoneutralizing endogenous PACAP, Immunocytochemistry showed that PACAP immunoreactivity is expressed in nerve terminals within freshly isolated rat islets, but not in islets that had been cultured for 48 h. In contrast, islet endocrine cells did not display PACAP immunoreactivity. :Addition of either of two specific PACAP antisera markedly inhibited glucose (11.1 mmol/l)-stimulated insulin secretion from freshly isolated rat islets, whereas a control rabbit serum did not affect glucose-stimulated insulin secretion. In:contrast, the PACAP antisera had no effect on glucose stimulated insulin secretion in cultured islets. Based on these results we therefore suggest that PACAP is an islet neuropeptide which is required for the normal insulinotropic action of glucose. (C) 1999 Academic Press.
引用
收藏
页码:664 / 667
页数:4
相关论文
共 22 条
[1]   Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells [J].
AfKlinteberg, K ;
Karlsson, S ;
Ahren, B .
ENDOCRINOLOGY, 1996, 137 (07) :2791-2798
[2]   NEUROPEPTIDERGIC VERSUS CHOLINERGIC AND ADRENERGIC REGULATION OF ISLET HORMONE-SECRETION [J].
AHREN, B ;
TABORSKY, GJ ;
PORTE, D .
DIABETOLOGIA, 1986, 29 (12) :827-836
[3]   PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND ITS RECEPTORS - NEUROENDOCRINE AND ENDOCRINE INTERACTION [J].
ARIMURA, A ;
SHIODA, S .
FRONTIERS IN NEUROENDOCRINOLOGY, 1995, 16 (01) :53-88
[4]   Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat [J].
Bertrand, G ;
Puech, R ;
Maisonnasse, Y ;
Bockaert, J ;
LoubatieresMariani, MM .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (04) :764-770
[5]   PACAP and PACAP receptors in insulin producing tissues: localization and effects [J].
Filipsson, K ;
Sundler, F ;
Hannibal, J ;
Ahren, B .
REGULATORY PEPTIDES, 1998, 74 (2-3) :167-175
[6]   PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice [J].
Filipsson, K ;
Pacini, G ;
Scheurink, AJW ;
Ahrén, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (05) :E834-E842
[7]   Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans [J].
Filipsson, K ;
Tornoe, K ;
Holst, J ;
Ahren, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) :3093-3098
[8]   Evidence for contribution by increased cytoplasmic Na+ to the insulinotropic action of PACAP38 in HIT-T15 cells [J].
Filipsson, K ;
Karlsson, S ;
Ahrén, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32602-32607
[9]   PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) - OCCURRENCE IN RODENT PANCREAS AND EFFECTS ON INSULIN AND GLUCAGON-SECRETION IN THE MOUSE [J].
FRIDOLF, T ;
SUNDLER, F ;
AHREN, B .
CELL AND TISSUE RESEARCH, 1992, 269 (02) :275-279
[10]  
Harmar AJ, 1998, PHARMACOL REV, V50, P265